Discover the core features of Claude Design, from setting up custom branding to exporting code-based designs to Figma and ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

CSL and uniQure’s gene therapy for haemophilia B has been approved by the European Commission, ushering in a new era of therapy for patients with the bleeding disorder in the EU. The therapy has been ...

It has been a tough period for CSL Ltd (ASX: CSL) shares. The biotechnology giant's shares ended the week at $143.19, which leaves them trading close to multi-year lows. Is this an opportunity to ...

Thousands of people living with a rare form of chronic kidney disease (CKD) in the UK will soon be able to access a new oral treatment – CSL Vifor's Filspari – that can help slow down the decline in ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Australia’s biggest biotech company CSL said it was assessing the impact of an executive order by US President Donald Trump, with early indications suggesting it would be largely exempt and face ...

Access detailed historical stock prices, including daily closing prices, for CSL. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...